NCT00020371View on ClinicalTrials.gov

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol SpecificNeutropenia
Interventions
DRUG

BMS-247550

DRUG

filgrastim

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020371 - BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy | Biotech Hunter | Biotech Hunter